|
1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar
|
|
2
|
Al-Tarawneh M, Khatib S and Arqub K:
Cancer incidence in Jordan, 1996–2005. East Mediterr Health J.
16:837–845. 2010.
|
|
3
|
Rowinsky EK and Donehower RC: Paclitaxel
(taxol). N Engl J Med. 332:1004–1014. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gonçalves A, Braguer D, Carles G, André N,
Prevôt C and Briand C: Caspase-8 activation independent of
CD95/CD95-L interaction during paclitaxel-induced apoptosis in
human colon cancer cells (HT29-D4). Biochem Pharmacol.
60:1579–1584. 2000.PubMed/NCBI
|
|
5
|
Bhalla KN: Microtubule-targeted anticancer
agents and apoptosis. Oncogene. 22:9075–9086. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Childs S, Yeh RL, Hui D and Ling V: Taxol
resistance mediated by transfection of the liver-specific sister
gene of P-glycoprotein. Cancer Res. 58:4160–4167. 1998.PubMed/NCBI
|
|
7
|
Lecureur V, Sun D, Hargrove P, et al:
Cloning and expression of murine sister of P-glycoprotein reveals a
more discriminating transporter than MDR1/P-glycoprotein. Mol
Pharmacol. 57:24–35. 2000.PubMed/NCBI
|
|
8
|
Subbaramaiah K, Hart JC, Norton L and
Dannenberg AJ: Microtubule-interfering agents stimulate the
transcription of cyclooxygenase-2. Evidence for involvement of
ERK1/2 and p38 mitogen-activated protein kinase pathways. J Biol
Chem. 275:14838–14845. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McDaid HM and Horwitz SB: Selective
potentiation of paclitaxel (taxol)-induced cell death by
mitogen-activated protein kinase kinase inhibition in human cancer
cell lines. Mol Pharmacol. 60:290–301. 2001.PubMed/NCBI
|
|
10
|
Mhaidat NM, Thorne RF, Zhang XD and Hersey
P: Regulation of docetaxel-induced apoptosis of human melanoma
cells by different isoforms of protein kinase C. Mol Cancer Res.
5:1073–1081. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Troppmair J, Bruder JT, Munoz H, et al:
Mitogen-activated protein kinase/extracellular signal-regulated
protein kinase activation by oncogenes, serum, and
12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary
for transformation. J Biol Chem. 269:7030–7035. 1994.
|
|
12
|
Hommes DW, Peppelenbosch MP and van
Deventer SJ: Mitogen activated protein (MAP) kinase signal
transduction pathways and novel anti-inflammatory targets. Gut.
52:144–151. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Davis RJ: Signal transduction by the JNK
group of MAP kinases. Cell. 103:239–252. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alessi DR, Saito Y, Campbell DG, et al:
Identification of the sites in MAP kinase kinase-1 phosphorylated
by p74raf-1. EMBO J. 13:1610–1619. 1994.PubMed/NCBI
|
|
15
|
Kavallaris M, Kuo DY, Burkhart CA, et al:
Taxol-resistant epithelial ovarian tumors are associated with
altered expression of specific beta-tubulin isotypes. J Clin
Invest. 100:1282–1293. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ranganathan S, Benetatos CA, Colarusso PJ,
Dexter DW and Hudes GR: Altered beta-tubulin isotype expression in
paclitaxel-resistant human prostate carcinoma cells. Br J Cancer.
77:562–566. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mhaidat NM, Thorne R, Zhang XD and Hersey
P: Involvement of endoplasmic reticulum stress in Docetaxel-induced
JNK-dependent apoptosis of human melanoma. Apoptosis. 13:1505–1512.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee AS: GRP78 induction in cancer:
therapeutic and prognostic implications. Cancer Res. 67:3496–3499.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma Y and Hendershot LM: ER chaperone
functions during normal and stress conditions. J Chem Neuroanat.
28:51–65. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wierzejska R: Caffeine - common ingredient
in a diet and its influence on human health. Rocz Panstw Zakl Hig.
63:141–147. 2012.(In Polish).
|
|
21
|
Tavares C and Sakata RK: Caffeine in the
treatment of pain. Rev Bras Anestesiol. 62:387–401. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roehrs T and Roth T: Caffeine: sleep and
daytime sleepiness. Sleep Med Rev. 12:153–162. 2008. View Article : Google Scholar
|
|
23
|
Glade MJ: Caffeine-not just a stimulant.
Nutrition. 26:932–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Okano J, Nagahara T, Matsumoto K and
Murawaki Y: Caffeine inhibits the proliferation of liver cancer
cells and activates the MEK/ERK/EGFR signalling pathway. Basic Clin
Pharmacol Toxicol. 102:543–551. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saunders DE, Lawrence WD, Christensen C,
Wappler NL, Ruan H and Deppe G: Paclitaxel-induced apoptosis in
MCF-7 breast-cancer cells. Int J Cancer. 70:214–220. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ribeiro JC, Barnetson AR, Jackson P, Ow K,
Links M and Russell PJ: Caffeine-increased radiosensitivity is not
dependent on a loss of G2/M arrest or apoptosis in bladder cancer
cell lines. Int J Radiat Biol. 75:481–492. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu YP, Lou YR, Lin Y, et al: Inhibitory
effects of orally administered green tea, black tea, and caffeine
on skin carcinogenesis in mice previously treated with ultraviolet
B light (high-risk mice): relationship to decreased tissue fat.
Cancer Res. 61:5002–5009. 2001.PubMed/NCBI
|
|
28
|
Lu YP, Lou YR, Peng QY, Xie JG and Conney
AH: Stimulatory effect of topical application of caffeine on
UVB-induced apoptosis in the epidermis of p53 and Bax knockout
mice. Cancer Res. 64:5020–5027. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nomura M, Ichimatsu D, Moritani S, et al:
Inhibition of epidermal growth factor-induced cell transformation
and Akt activation by caffeine. Mol Carcinog. 44:67–76. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He Z, Ma WY, Hashimoto T, Bode AM, Yang CS
and Dong Z: Induction of apoptosis by caffeine is mediated by the
p53, Bax, and caspase 3 pathways. Cancer Res. 63:4396–4401.
2003.PubMed/NCBI
|
|
31
|
Hashimoto T, He Z, Ma WY, et al: Caffeine
inhibits cell proliferation by G0/G1 phase arrest in JB6 cells.
Cancer Res. 64:3344–3349. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bode AM and Dong Z: The enigmatic effects
of caffeine in cell cycle and cancer. Cancer Lett. 247:26–39. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mhaidat NM, Alali FQ, Matalqah SM, et al:
Inhibition of MEK sensitizes paclitaxel-induced apoptosis of human
colorectal cancer cells by downregulation of GRP78. Anticancer
Drugs. 20:601–606. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang K and Kaufman RJ: Protein folding in
the endoplasmic reticulum and the unfolded protein response. Handb
Exp Pharmacol. 69–91. 2006. View Article : Google Scholar
|
|
35
|
Szegezdi E, Logue SE, Gorman AM and Samali
A: Mediators of endoplasmic reticulum stress-induced apoptosis.
EMBO Rep. 7:880–885. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tabas I and Ron D: Integrating the
mechanisms of apoptosis induced by endoplasmic reticulum stress.
Nat Cell Biol. 13:184–190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lyles MB and Cameron IL: Caffeine and
other xanthines as cytochemical blockers and removers of
heterocyclic DNA intercalators from chromatin. Cell Biol Int.
26:145–154. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Geraets L, Moonen HJ, Wouters EF, Bast A
and Hageman GJ: Caffeine metabolites are inhibitors of the nuclear
enzyme poly(ADP-ribose)polymerase-1 at physiological
concentrations. Biochem Pharmacol. 72:902–910. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Howell LL: Comparative effects of caffeine
and selective phosphodiesterase inhibitors on respiration and
behavior in rhesus monkeys. J Pharmacol Exp Ther. 266:894–903.
1993.PubMed/NCBI
|
|
40
|
Shinomiya N, Shinomiya M, Wakiyama H,
Katsura Y and Rokutanda M: Enhancement of CDDP cytotoxicity by
caffeine is characterized by apoptotic cell death. Exp Cell Res.
210:236–242. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lock RB, Galperina OV, Feldhoff RC and
Rhodes LJ: Concentration-dependent differences in the mechanisms by
which caffeine potentiates etoposide cytotoxicity in HeLa cells.
Cancer Res. 54:4933–4939. 1994.PubMed/NCBI
|
|
42
|
Kitamoto Y, Sakurai H, Mitsuhashi N,
Akimoto T and Nakano T: Caffeine diminishes cytotoxic effects of
paclitaxel on a human lung adenocarcinoma cell line. Cancer Lett.
191:101–107. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang PL, Lun M, Teng J, et al: Preinduced
molecular chaperones in the endoplasmic reticulum protect
cardiomyocytes from lethal injury. Ann Clin Lab Sci. 34:449–457.
2004.PubMed/NCBI
|
|
44
|
Ostergaard L, Simonsen U,
Eskildsen-Helmond Y, et al: Proteomics reveals lowering oxygen
alters cytoskeletal and endoplasmatic stress proteins in human
endothelial cells. Proteomics. 9:4457–4467. 2009. View Article : Google Scholar
|
|
45
|
Martinou JC and Green DR: Breaking the
mitochondrial barrier. Nat Rev Mol Cell Biol. 2:63–67. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Adams JM and Cory S: The Bcl-2 protein
family: arbiters of cell survival. Science. 281:1322–1326. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ding Q, Huo L, Yang JY, et al:
Down-regulation of myeloid cell leukemia-1 through inhibiting
Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in
breast cancer. Cancer Res. 68:6109–6117. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wesarg E, Hoffarth S, Wiewrodt R, et al:
Targeting BCL-2 family proteins to overcome drug resistance in
non-small cell lung cancer. Int J Cancer. 121:2387–2394. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang Z, Xie Y and Wang H: Changes in
survivin messenger RNA level during chemotherapy treatment in
ovarian cancer cells. Cancer Biol Ther. 4:716–719. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Boucher MJ, Morisset J, Vachon PH, Reed
JC, Lainé J and Rivard N: MEK/ERK signaling pathway regulates the
expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of
human pancreatic cancer cells. J Cell Biochem. 79:355–369. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hu P, Han Z, Couvillon AD and Exton JH:
Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in
counteracting endoplasmic reticulum stress-induced cell death. J
Biol Chem. 279:49420–49429. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang YF, Jiang CC, Kiejda KA, Gillespie S,
Zhang XD and Hersey P: Apoptosis induction in human melanoma cells
by inhibition of MEK is caspase-independent and mediated by the
Bcl-2 family members PUMA, Bim, and Mcl-1. Clin Cancer Res.
13:4934–4942. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
O'Connor L, Strasser A, O'Reilly LA, et
al: Bim: a novel member of the Bcl-2 family that promotes
apoptosis. EMBO J. 17:384–395. 1998. View Article : Google Scholar
|
|
54
|
Cheng EH, Wei MC, Weiler S, et al: BCL-2,
BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and
BAK-mediated mitochondrial apoptosis. Mol Cell. 8:705–711. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Korsmeyer SJ, Wei MC, Saito M, Weiler S,
Oh KJ and Schlesinger PH: Pro-apoptotic cascade activates BID,
which oligomerizes BAK or BAX into pores that result in the release
of cytochrome c. Cell Death Differ. 7:1166–1173. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bouillet P, Purton JF, Godfrey DI, et al:
BH3-only Bcl-2 family member Bim is required for apoptosis of
autoreactive thymocytes. Nature. 415:922–926. 2002. View Article : Google Scholar : PubMed/NCBI
|
